| Name | Title | Contact Details |
|---|---|---|
Angie Goldsberry |
Vice President, Product Development | Profile |
Melanie Chin |
VP Product Strategy | Profile |
Colin Meyer |
Chief Research and Development Officer | Profile |
Bhaskar Anand |
Chief Accounting Officer (CAO) | Profile |
Steve Harman |
Vice President, Chief Human Resources Officer | Profile |
Nutra Lab Canada Inc. is a Markham, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Theseus is a biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development and commercialization of transformative targeted therapies. Theseus is developing next-generation tyrosine kinase inhibitors (TKIs): "pan-variant" targeted therapies that address all major drug resistance mutations. Theseus` lead product candidate, THE-630, is a pan-variant KIT inhibitor for the treatment of patients with advanced gastrointestinal stromal tumors (GIST), whose cancer has developed resistance to earlier lines of kinase inhibitor therapy. Theseus is also developing a fourth-generation, selective epidermal growth factor receptor (EGFR) inhibitor for C797S-mediated resistance to first- or later-line osimertinib treatment in patients with non-small cell lung cancer (NSCLC).
Deltanoid Pharmaceuticals is a Madison, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.